Ischemic Optic Neuropathy clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
The purpose of the study is to use new diagnostic methods (OCT and OCT-A) to shed light on risk factors for the development of NA-AION. The risk factors we are focusing on are comorbidities along with anatomical and vascular characteristics of the optic nerve.
San Francisco, California and other locations
Our lead scientists for Ischemic Optic Neuropathy research studies include Nailyn Rasool.